Join
Live feed
·
INSIDERFilingvia Quantisnow
Niagen Bioscience Inc. logo

Chief Financial Officer Pamir Ozan was granted 4,255 shares, increasing direct ownership by 58% to 11,627 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NAGE· Niagen Bioscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAGE (Niagen Bioscience Inc.) and more on Quantisnow.